Announcements Trials
Browse Landscape

Phase

Phase 2 81Phase 1 37Phase NA 30Phase 1/2 28Phase 3 11Phase EARLY_PHASE1 4Phase 4 1Phase 2/3 1

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Sarcoma 1Plasma cell 1Head & Neck 1Dermatologic 1

Conditions

Glioblastoma 16Glioma 14Neoplasms 13Breast Neoplasms 13Prostatic Neoplasms 12Brain Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 8Lymphoma, B-Cell 8Pancreatic Neoplasms 7Multiple Myeloma 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Recurrence 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Skin Neoplasms 4Lymphoma 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, Follicular 3Lung Neoplasms 3Colonic Neoplasms 3Astrocytoma 3

Interventions

fludarabine 2Cyclophosphamide 2pembrolizumab 1fludarabine phosphate 1brexucabtagene autoleucel 1acalabrutinib 1Rituximab 1Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma × 90 days × Clear all
NCT04541108 2026-05-22

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Presage Biosciences

Phase EARLY_PHASE1 Active not recruiting
15 enrolled
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT05495464 2026-05-20

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Affiliated Hospital to Academy of Military Medical Sciences

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT05294367 2026-03-16

Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

Mayo Clinic

Phase EARLY_PHASE1 Recruiting
60 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡